For oligodendrocytes—the central nervous system cells critical for brain function—age may not bring wisdom, but it does come with the power to cling to life for much, much longer than scientists knew. That's according to a new study featured on the cover of the Journal of Neuroscience.
Mature oligodendrocytes took a shocking 45 days to die following a fatal trauma that killed younger cells within the expected 24 hours, the researchers report. The findings suggest there's a new pathway for efforts to reverse or prevent the damage that aging and diseases such as multiple sclerosis cause to these important cells.
In the brain, oligodendrocytes wrap around the long, skinny connections between nerve cells known as axons, where they produce a lipid membrane called a myelin sheath that coats the axon. Axons transmit the electrical signals that nerve cells use to communicate; myelin sheaths—like the plastic coating on a copper wire—help these signals travel more efficiently.
Old age and neurodegenerative diseases like MS damage oligodendrocytes. When the cells die, their myelin production perishes with them, causing myelin sheaths to break down with nothing to replenish them. This can lead to the loss of motor function, feeling, and memory as neurons lose the ability to communicate.
Scientists have assumed that damaged oligodendrocytes—like all injured cells—initiate a cellular self-destruct called apoptosis in which the cells kill themselves. But the researchers discovered that mature oligodendrocytes can experience an extended life before their death that has never been seen before. The findings pose the critical question of what in these cells changes as they mature that allows them to persist.
"We found that mature cells undertake a pathway that is still controlled, but not the classical programmed cell-death pathway," said the corresponding author of the paper.
"We think this is showing us what happens in brains as we age and revealing a lot about how these cells die in older people," the author said. "That unique mechanism is important for us to investigate further. We need to understand why these cells are following this pathway so we can potentially encourage or prevent it, depending on the disease context."
First author said that efforts to develop treatments for preserving myelin have focused on cultivating young oligodendrocytes and protecting mature ones. But this study suggests the cells may change significantly as they age and that a one-size-fits-all treatment might not work.
"In response to the same thing, young cells go one way and old cells go another," said the author. "If you wanted to protect the old cells, you may have to do something completely different than if you wanted to help the young cells mature. You'll likely need a dual approach."
The paper builds on a living-tissue model the team reported in the journal Nature Neuroscience in March 2023 that allows them to initiate the death of a single oligodendrocyte to observe how the cells around it react. They reported that when an oligodendrocyte in a young brain died, the cells around it immediately replenished the lost myelin. In a brain equivalent to that of a 60-year-old, however, the surrounding cells did nothing and the myelin was lost.
"That model gets us as close as we can get to the cell-death process that happens in the brain," the senior author said. "We're able to model the effects of aging really well. Our ability to select a single oligodendrocyte, watch it die, and watch it regenerate or fail to regenerate allows us to understand what drives this process at the cellular level and how it can be controlled."
For the latest study, the researchers used their model to fatally damage oligodendrocyte DNA using what amounts to a cellular death ray—a photon-based device called 2Phatal that Hill developed. They also used the standard method for removing myelin that uses the copper-based toxin cuprizone as a comparison.
As previous studies have reported, the immature cells died quickly. But the older cells lived on, which the Dartmouth team at first interpreted as a resistance to DNA damage.
The study came into focus when the researchers examined the mature cells 45 days later using a long-term, high-resolution imaging technique developed in the lab . "That's when we saw that it wasn't that the cells were resistant to damage—they were experiencing this extended cell death instead," the senior author said.
"No one's ever checked for cell death that long after DNA damage. It's the only example we can find in the literature where a cell experiences such a traumatic event and sticks around longer than a week," the author said.
Because humans have oligodendrocytes for life, the cells are known to accumulate DNA damage and be more resilient than other cells, the lead said. "That's why we think this effect is applicable to aging. One reason these cells may persist for such a long time is because they're used to experiencing this kind of damage naturally in aging," the author said.
The study opens the first door of a vast labyrinth of more questions, the authors say, such as whether the extended death is a good thing. It may be the equivalent of dysfunctional myelin, which is worse just sitting on an axon than if there was no myelin at all, the senior author said. It isolates the cell from the surrounding tissue and essentially starves it of nutrients.
"It's almost like there is garbage sitting on the axon for 45 days. Do we want to save that garbage or speed up its removal? We didn't even know that was a question until we saw this," the author said.
"If we understand the cell-death mechanism, maybe we can speed it up and get rid of that dysfunctional myelin," the author said. "We're always trying to save the cells and save the tissue, but you have to know if they're worth saving."
https://www.jneurosci.org/content/44/13/e1794232024
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Foligodendrocyte_2&filter=22
Myelin producing cells linger unexpectedly before their death
- 779 views
- Added
Latest News
Pan-cancer proteogenomics e…
By newseditor
Posted 05 Jul
Fertility treatments could…
By newseditor
Posted 05 Jul
Extended-release ketamine t…
By newseditor
Posted 05 Jul
How an unstructured protein…
By newseditor
Posted 04 Jul
Precise control of endogeno…
By newseditor
Posted 04 Jul
Other Top Stories
Antibody and drug transport in human microfluidic Blood-Brain Barri…
Read more
New functions of stem cell protein involved in some tumors and rare…
Read more
Neurons from stem cells used to study drug-induced neurodevelopment…
Read more
A chemical in the processed food linked to autism
Read more
How gastric stem cells fight bacteria
Read more
Protocols
Pan-cancer proteogenomics c…
By newseditor
Posted 05 Jul
A systems biology-based ide…
By newseditor
Posted 05 Jul
Tongue orthotopic xenograft…
By newseditor
Posted 04 Jul
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Publications
Prevention of Falls in Olde…
By newseditor
Posted 05 Jul
The primitive endoderm supp…
By newseditor
Posted 05 Jul
Migrasome biogenesis: when…
By newseditor
Posted 05 Jul
Extended-release ketamine t…
By newseditor
Posted 05 Jul
Regulation of stress-induce…
By newseditor
Posted 04 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar